Previous studies have provided evidence that women with low serum 25-OH-D3 levels and high tissue levels of VDR and ERα gene expression not only had increased risk for breast cancer [12] but also had worsened cancer prognosis and decreased survival rates as compared to patients with other cancers [13]. Here, ESR1 is linked to breast carcinoma.